Pacira Share Price

Pacira Share Price

NASDAQ: PCRX | Healthcare
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Pacira Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Pacira Share Price Chart

$0.00$0.00
L
Show Current Price
H

Pacira Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
38.59
Dividend Yield
0.00%
EPS (TTM)
$0.95
Revenue (TTM)
$726.41B
Return On Equity (TTM)
5.30%
Profit Margin
0.97%
Debt to Equity
0.41
Quarterly Earnings Growth YoY
1639.02%

Pacira Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$196.87$177.38$192.40$176.65
Net Profit$1.64$2.92$4.65$28.52
Net Profit Margin0.83%1.65%2.42%16.14%
Income ChangeN/A78.05%59.25%513.33%

Pacira Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$666.82$674.98$700.97$726.41
Net Profit$15.91$41.96-$99.56$7.03
Net Profit Margin2.39%6.22%-14.20%0.97%
Income ChangeN/A163.73%-337.27%107.06%

Pacira Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets716.94808.391064.391182.87
Current Assets547.97745.13509.99498.33
Total Assets1264.921553.521574.391681.2
Non Current Liabilities451.22465.25606.87758.42
Current Liabilities120.59309.9297.38147.77
Total Liabilities571.81775.17704.26906.19
Shareholders' Equity693.11778.35870.13775.01

Pacira Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating151.99189.39154.65174.75
Investing99.48-83.2877.54-225.19
Financing-369.6317.36-183.03-431.0

About Pacira

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Pacira Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %

Pacira Share Price FAQs